Amanda Black profile picture

Contact Information

Amanda Black, MD, MPH, FRCSC
613-738-8400 x81799

ORCID logo

Research Activities

2015              A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with Overactive Bladder (OAB) – PILLAR.  Co-Investigator (Ottawa Site) 
2015              Group education and decision coaching in women’s pelvic health:  A Randomized Control Trial. Co-Investigator     
2014 - 2015     Cost of unintended pregnancies and the impact of increase use of long-acting reversible contraceptives in Canada.  Principal Investigator. Funded in part through Eunice Kennedy Shriver National Institute of Child Health and Human Development grant for Infrastructure for Population Research at Princeton University, Grant R24HD047879 (Dr. James Trussell).  
2014 -  2016            A Randomized, Parallel-Group, Double-Blind, placebo-controlled, multi-center study to Assess the Efficacy and Safety of Difference doses of BAY 1002670 in Subjects with Uterine Fibroids over 3 months. Co-Investigator (Ottawa Site)  
2014 -  2016            Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia – Folic Acid Clinical Trial (FACT).  Canadian Institutes of Health Research (CIHR).  Principal Investigators:  Dr. Mark Walker, Dr. Shi Wu Wen (Ottawa)  Co-Investigator (Ottawa site)   2014 - 2016             A Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Efficacy and Safety of Ulipristal Acetate for the Intermittent Treatment of Abnormal Uterine Bleeding associated with Leiomyomas. Watson/Actavis. Co-Investigator (Ottawa site)
2014-               Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain. Co-Investigator (Ottawa site)    
2013- 2015              Immunization of Women with Diphtheria and Tetanus Toxoids Combined with Acellular Pertussis (Tdap) During the Mid Third Trimester of Pregnancy: An Evaluation of the Potential for Immunological Protection for the Neonate Co-Investigator (Ottawa site)
2012-  2015             A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects with Endometriosis Associated Pain. OHREB Approved Co-Investigator (Ottawa site)
2012-2014       Health Advocacy Training in Postgraduate Obstetrics and Gynecology: Evaluation of a New Curriculum Through OSCE’s. Co-investigator Grant: Physician’s Services Incorporated Foundation Resident Grant                          
2010-2012       Evaluation of A Unique Canadian Community Outreach Program Providing Obstetrical Care for Pregnant Adolescents:  A Matched Cohort Study.  Co-Investigator Support:  The TOHAMO Innovation Award                          
2009-2012       Teaching Health Advocacy in Ob/Gyn Residency at the University of Ottawa.  Co-Investigator Support:  The Educational Initiatives in Residency Education Fund, University of Ottawa.
2009-2012       Multi-centre, randomized, double-blind, active controlled, parallel group, 2-arm study to show superiority of the oral contraceptive SH T00658ID to Ortho Tri-Cyclen Lo on hormone withdrawal-associated symptoms after 6 cycles of treatment. Primary Investigator (Ottawa Site)
2009                A National Survey of Sources of Health Information in Canada.  Support:  The Society of Obstetricians and Gynecologists of Canada’s Contraception Awareness Program.  Principal Investigator
2009                Comparison of the Continuous Versus Cyclic Use of a 30-mcg Ethinyl Estradiol/0.15-mg Desogestrel Oral Contraceptive Pill in Adolescents.  Primary Investigator (Ottawa Site)  Support: Physicians Services Incorporated (PSI) grant                          
2009                Characteristics of Women Undergoing Repeat Abortion:  10 Year Follow Up.  Co-Investigator.  In collaboration with Drs. W. Fisher and P. Shuper, The University of Western Ontario, London, Ontario.                          
2007                A National Landscape Survey of Contraceptive Patterns and Sexual Behaviours in Canadian Women.                         Primary Investigator. Support: The Society of Obstetricians and Gynaecologists of Canada Contraception Awareness Program    
2007                Travel to Access Reproductive Health Services Study.  Consultant Ob/Gyn as medical expert in contraception and pregnancy termination Primary Investigator:  Professor C. Sethna, University of Ottawa (grant holder) Support:  Social Sciences and Humanities Research Council Grant                           
2007                 Multi-center, open-label, randomized study to assess the safety and contraceptive efficacy of two doses (in vitro 12 µg/24 h and 16 µg /24 h) of the ultra low dose levonorgestrel contraceptive intrauterine systems (LCS) for a maximum of 3 years in women 18 to 35 years of age. Primary Investigator (Ottawa Site)
2006-2009       A Randomized, Open-Label, Comparative, Multi-Center Trial to Evaluate Contraceptive Efficacy, Cycle Control, Safety, and Acceptability of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5 mg Estradiol (E2), Compared to a Monophasic COC Containing 3 mg Drosperinone (DRSP) and 30 mcg Ethinyl Estradiol (EE).                     Primary Investigator, Ottawa Site                           

 2016 -              Testing HIV Curative Strategies in a Humanized Mouse Model.  Co-investigator (Principal Investigator:  Dr. Jonathan Angel  
 2014 -              Understanding the molecular basis of placental mediated diseases. Co-Investigator. (Primary Investigator:  Dr. Shannon Bainbridge)  
2014 – 2016    Improving maternal health in India and Canada through knowledge building and participatory design of educational material on upright birthing positions.  Collaborator  
2012 -              Implementation of an HPV Catch-Up Vaccination Program in High-Risk Adolescent Women. Co-Investigator                         2012 - 2013     Using Photovoice as a Strategy to Elicit the Determinants of Reproductive and Sexual Health that Impact Adolescent Mothers. Co-Investigator  
2012 - 2013     Objective Assessment of a Pediatric and Adolescent Gynecology Simulation Curriculum via Pre and Post- Objective Structured Clinical Examinations. Co-Investigator  
2012- 2014      Assessing the Need for an HPV Catch-Up Vaccination Program in Higher-Risk Adolescent Women. Co-Investigator   2012 -              Rates of Sexually Transmitted Infections in Pregnant Canadian Adolescents: A Prospective Cohort Study.                         Principal Investigator  
2012 - 2014     Knowledge and Understanding of Epidemiological Principles in Canadian Postgraduate Trainees.                         Principal Investigator  
2010                Contraceptive Use Among Canadian Adolescent Women:  Patterns, Adherence, and Barriers to Use                         Principal Investigator  
2010                Temporary Uterine Artery Embolization Prior to Elective Uterine Myomectomy:  A case series Principal Investigator
2009-2012       Violence in Adolescent Pregnancy in Canada:  A prospective cohort study. Co-investigator  
 2009-2011       St. Mary’s Home:  A unique Canadian community outreach program providing obstetrical and post-partum contraceptive care for pregnant adolescents.  Co-investigator